4 demographic factors with year were examined using negative binomial regression. Spearman rank correlation examined the compensatory effect between increasing mortality from unintentional suffocation and decreasing mortality from sudden infant death syndrome (ICD-10 codes R95) that was previously suggested by Shapiro-Mendozaet al 6 using mortality rates from 1984 to 2004. All statistical analyses were conducted using Stata, version 12.1 (StataCorp), with P < .05 considered to be statistically significant.
Results | From 1999 to 2015, unintentional infant mortality from suffocation among infants younger than 1 year increased from 12.4 to 28.3 per 100 000 persons (rate ratio, 2.27; 95% CI, 2.04-2.53) (Table) . Despite some variation in the increase in mortality between 1999 and 2015 across demographic subgroups (rate ratios ranging from 1.90 to 2.77), the increase in mortality occurred in all subgroups by sex (male and female), race (white and black), ethnicity (Hispanic and non-Hispanic), and urbanization (urban and rural areas). Interaction analyses indicated that the change in mortality did not differ significantly across the demographic subgroups. The Figure shows that the increase in suffocations and strangulations in bed was the primary driver of the substantial increase in overall mortality from unintentional suffocation among US infants younger than 12 months between 1999 and 2015.
Results of Spearman correlation analysis showed a negative correlation between increasing mortality from unintentional suffocation and decreasing mortality from sudden infant death syndrome from 1999 to 2015 (r s = -0.63).
Discussion | The continuous increase of unintentional suffocation from 1999 to 2015 among US infants younger than 12 months is concerning. Our results show that the increase was primarily a result of increases in deaths from suffocation and strangulation in bed.
Multiple stakeholders have recently addressed safe sleep for infants, promoting interventions such as safe sleeping without blankets, stuffed animals, and other risks; reduction of cosleeping 2,3 ; and removal of unsafe baby products, such as some infant sleep positioners that are not approved by the US Food and Drug Administration but were marketed to the general public. 7 Despite these efforts, our results indicate that infant deaths from suffocation are continuing and efforts by government and nongovernment agencies must continue and be enhanced.
There is insufficient evidence to interpret the mechanism behind our results, especially the 1.27-fold increase in mortality. The observed increase is likely associated with multiple factors, including use of unsafe products and improved differentiation between suffocation and sudden infant death syndrome in death certificate reporting.
6 Regardless of the cause, our data indicate more than 1100 preventable infant deaths occurred in 2015, a statistic that warrants attention and action.
Yuyan Gao, BM David C. Schwebel, PhD Guoqing Hu, PhD Because the end point of hypoxemia is altered tissue oxygenation, we believe that oxygen consumption is more important than oxygen content. Oxygen consumption is calculated from cardiac output and the delta between arterial and mixed venous oxygen content.
2 Most parameters affecting hemoglobin oxygen affinity act in a similar manner in arterial and venous blood. Thus, a higher SaO 2 without a change in PaO 2 probably does not improve oxygen consumption even if it is associated with an increase in oxygen content. We believe the latest statement might be even more important in neonates who undergo a blood transfusion. Indeed, a relative decrease in the proportion of fetal hemoglobin after blood transfusion may dramatically affect hemoglobin affinity, subsequently leading to an increase in oxygen blood content without any change in oxygen consumption. 3 Furthermore, it is likely that oxygen toxicity occurs mainly from the free fraction of oxygen dissolved in plasma and not from the oxygen bound to hemoglobin. 4 The risk for oxygen toxicity is a major incentive to PaO 2 monitoring in premature neonates. We thus believe that, when available, PaO 2 should still be considered the gold standard of oxygenation monitoring.
